Jazz Pharmaceuticals (JAZZ)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Jazz Pharmaceuticals | JAZZ | Healthcare | Biotechnology | 61 | 7.9% |
| Current Price (01/27) | $135.05 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 2,863.0 | |||
| Sales Growth Forecast | 12.0% | |||
| Net Profit Margin | 28.2% | |||
| Projected Shares Outstanding | 65.03 | |||
| EPS - Five year Forecast | $21.92 | |||
| Average P/E Ratio | 9.0 | |||
| Projected Average Price | $197.29 | |||
| Price Appreciation (Annualized) | 7.9% | |||
| Annual Dividend Yield | 0.0% | |||
| Projected Annual Return | 7.9% | |||
| Quality | ||||
| Financial Strength | 76 | 18.9 | ||
| EPS Stability | 53 | 13.2 | ||
| Industry Sales Growth Rate | 15.0% | 10.0 | ||
| Industry Net Profit Margin | 30.0% | 11.8 | ||
| Calculated Quality Rating | 53.9 | |||
| Fool CAPS | ||||
Total Players
284
Outperforms
67
Underperforms
All-Stars (62)
47
Outperforms (76%)
15
Underperforms
|
||||
| Fundamental Data Updated: 12/10/2021 | ||||